Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus

Clinical Focus ›› 2014, Vol. 29 ›› Issue (11): 1243-1245.

Previous Articles Next Articles

Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus

HUANG Zhi-fang;LI Xin-lun;LI Hong-xia;LUN Li-de

Online:2014-11-05 Published:2014-11-05

Abstract

CLC Number:

R593.241

HUANG Zhi-fang;LI Xin-lun;LI Hong-xia;LUN Li-de. Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus[J]. Clinical Focus, 2014, 29(11): 1243-1245.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2014/V29/I11/1243

[1]	Fu Shuxia1, Fu Shuli2. Advances in the treatment of idiopathic membranous nephropathy [J]. Clinical Focus, 2019, 34(12): 1061-1065.
[2]	Li Shengmian. Rational application of corticosteroids in ulcerative colitis [J]. Clinical Focus, 2016, 31(8): 828-830,837.
[3]	Li Yue， Qian Jiaming. Recent advances of immunosuppressive therapy in inflammatory bowel disease [J]. Clinical Focus, 2016, 31(8): 824-827.
[4]	Gao Lixia. Diagnosis and treatment advances of IgG4related disease [J]. Clinical Focus, 2016, 31(5): 501-505.
[5]	Gao Yuan;Meng Qinghua;Liu Haixia;Zhu Yueke. Abnormal liver function as the first symptom of systemic lupus erythematosus: analysis of 15 cases [J]. Clinical Focus, 2015, 30(7): 806-810.
[6]	Quan Feng;Fan Xuemei;Fang Wenlong. Clinical study of systemic lupus erythematosus associated pulmonary hypertension [J]. Clinical Focus, 2015, 30(12): 1402-1.40414e+007.
[7]	LI Hong-bo;ZHANG Jing-kun;WU Chao;WANG Ji;ZHANG Yu-jun;GAO Li-xia. Relationship of high mobility group protein 1,Toll-like receptors 4, vascular endothelial cell adhesion molecule-1 expression in lupus nephritis with dyslipidemia [J]. Clinical Focus, 2014, 29(8): 891-895.
[8]	YE Li;TONG Hong-yan. Standardized and novel treatments for patients with myelodysplastic syndromes:an update [J]. Clinical Focus, 2014, 29(10): 1095-1099.
[9]	PENG Jun. Advances in the treatment of refractory/relapsed immune thrombocytopenia [J]. Clinical Focus, 2014, 29(10): 1091-1094.
[10]	WU Yu;XU Juan. Advances in the treatment of hemolytic anemia [J]. Clinical Focus, 2014, 29(10): 1087-1.09011e+007.
[11]	WANG Lu;HAN Bing. Recent progresses in the treatment of aplastic anemia [J]. Clinical Focus, 2014, 29(10): 1083-1086.

Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments